EnteroBiotix: EnteroBiotix completes patient recruitment in phase 2 TrIuMPH study of EBX10202 in irritable bowel syndrome
EnteroBiotix Limited (EnteroBiotix), a clinical─stage biotechnology company focussed on developing best─in─class full─spectrum microbiome therapeutics, announced the completion of recruitment in its phase 2
Read full article »
EnteroBiotix is a Scotland-based biotechnology company that researches and develops novel microbiome-modulating therapeutics for the treatment of bacterial infections.
Read more